a manufacturer of antibody-based medicines
Industry Biotechnology
A.I.dvisor indicates that over the last year, ARGX has been loosely correlated with BBIO. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ARGX jumps, then BBIO could also see price increases.
Ticker / NAME | Correlation To ARGX | 1D Price Change % | ||
---|---|---|---|---|
ARGX | 100% | -0.72% | ||
BBIO - ARGX | 46% Loosely correlated | -2.74% | ||
NRBO - ARGX | 43% Loosely correlated | -6.64% | ||
ROIV - ARGX | 43% Loosely correlated | -2.59% | ||
BLUE - ARGX | 42% Loosely correlated | -3.64% | ||
IMVT - ARGX | 37% Loosely correlated | -2.94% | ||
More |
Ticker / NAME | Correlation To ARGX | 1D Price Change % |
---|---|---|
ARGX | 100% | -0.72% |
antibody theme (6 stocks) | 99% Closely correlated | -4.63% |
pharmaceuticals theme (159 stocks) | 44% Loosely correlated | -1.90% |
europe theme (179 stocks) | 23% Poorly correlated | -0.09% |